ACE2 and COVID-19: Moreover, the increased mortality in COVID-19 is associated with conditions, which are associated with endothelial dysfunction, low ACE2 expression, and high circulating plasminogen levels (Tikellis and Thomas, 2012; Derhaschnig et al., 2013).